Guidelines for diagnosis, prevention and treatment of hand eczema - Short version;Leitlinie für die diagnose, prävention und behandlung des handekzems - Kurzversion

JDDG - Journal of the German Society of Dermatology

Volumn 13, Issue 1, 2015, Pages 77-85

  Diepgen, Thomas L ^a   Andersen, Klaus E ^b   Chosidow, Oliver ^c   Coenraads, Peter Jan ^d   Elsner, Peter ^e   English, John ^f   Fartasch, Manigé ^g   Gimenez Arnau, Ana ^h   Nixon, Rosemary ⁱ   Sasseville, Denis ^j   Agner, Tove ^k  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c HENRI MONDOR HOSPITAL   (France)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^e JENA UNIVERSITY HOSPITAL   (Germany)

^f UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^g RUHR UNIVERSITY BOCHUM   (Germany)

^h UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

ⁱ Occupational Dermatology Research and Education Centre   (Australia)

^j ROYAL VICTORIA HOSPITAL   (Canada)

^k UNIVERSITY OF COPENHAGEN   (Denmark)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; ANTIHISTAMINIC AGENT; AZATHIOPRINE; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN; EMOLLIENT AGENT; ETRETIN; IMMUNOGLOBULIN; INFLIXIMAB; INTERFERON; METHOTREXATE; DERMATOLOGICAL AGENT;

ANAMNESIS; ARTICLE; CLINICAL EXAMINATION; CONSENSUS; DERMATITIS; DISEASE CLASSIFICATION; DRUG EFFICACY; HAND ECZEMA; HUMAN; HUMIDIFIER; LIFESTYLE MODIFICATION; LONG TERM CARE; MAINTENANCE THERAPY; PATCH TEST; PATIENT EDUCATION; PHOTOTHERAPY; PHYSIOTHERAPY; PRACTICE GUIDELINE; PRIMARY PREVENTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SECONDARY PREVENTION; SKIN PROTECTION; SYSTEMIC THERAPY; DERMATOLOGY; ECZEMA; EUROPE; EVIDENCE BASED MEDICINE; GERMANY; HAND DERMATOSES; PROTECTIVE CLOTHING; STANDARDS; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; ADRENAL CORTEX HORMONES; DERMATOLOGIC AGENTS; DERMATOLOGY; ECZEMA; EUROPE; EVIDENCE-BASED MEDICINE; GERMANY; GLOVES, PROTECTIVE; HAND DERMATOSES; HUMANS; PRACTICE GUIDELINES AS TOPIC; TREATMENT OUTCOME;

EID: 84920830003     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/ddg.12510     Document Type: Article

References (30)

1. Coenraads PJ, Christoffers WA, Svensson A et al. Interventions for hand eczema. Cochrane Database, resubmitted to the Cochrane Database of Systematic Reviews June 2014.
2. Lynde C, Guenther L, Diepgen TL et al. Canadian hand dermatitis management guidelines. J Cutan Med Surg 2010; 14: 267-84.
3. Coenraads PJ, Diepgen TL. Problems with trials and intervention studies on barrier creams and emollients at the workplace. Int Arch Occup Environ Health 2003; 76: 362-6.
4. Kucharekova M, Van De Kerkhof PC, Van Der Valk PG. A randomized comparison of an emollient containing skin-related lipids with a petrolatum-based emollient as adjunct in the treatment of chronic hand dermatitis. Contact Dermatitis 2003; 48: 293-9.
5. Pedersen LK, Held E, Johansen JD, Agner T. Short-term effects of alcohol-based disinfectant and detergent on skin irritation. Contact Dermatitis 2005; 52: 82-7.
6. Bauer A, Schmitt J, Bennett C et al. Interventions for preventing occupational irritant hand dermatitis. Cochrane Database Syst Rev 2010: CD004414.
7. Agner T, Held E. Skin protection programmes. Contact Dermatitis 2002; 47: 253-6.
8. Held E, Lund H, Agner T. Effect of different moisturizers on SLS-irritated human skin. Contact Dermatitis 2001; 44: 229-34.
9. 2. Acta Derm Venereol 2003; 83: 93-7.
10. Veien NK, Larsen PO, Thestrup-Pedersen K, Schou G. Long-term, intermittent, treatment of chronic hand eczema with mometasone furoate. Br J Dermatol 1999; 140: 882-6.
11. Kao JS, Fluhr JW, Man MQ et al. Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities. J Invest Dermatol 2003; 120: 456-64.
12. Baeck M, Goossens A. Immediate and delayed allergic hypersensitivity to corticosteroids: practical guidelines. Contact Dermatitis 2012; 66: 38-45.
13. Krejci-Manwaring J, McCarty MA, Camacho F et al. Topical tacrolimus 0.1 % improves symptoms of hand dermatitis in patients treated with a prednisone taper. J Drugs Dermatol 2008; 7: 643-6.
14. Belsito DV, Fowler JF, Jr., Marks JG, Jr. et al. Pimecrolimus cream 1 %: a potential new treatment for chronic hand dermatitis. Cutis 2004; 73: 31-8.
15. Nijsten TE, Stern RS. The increased risk of skin cancer is persistent after discontinuation of psoralen+ultraviolet A: a cohort study. J Invest Dermatol 2003; 121: 252-8.
16. Sjovall P, Christensen OB. Treatment of chronic hand eczema with UV-B Handylux in the clinic and at home. Contact Dermatitis 1994; 31: 5-8.
17. Heddle RJ, Soothill JF, Bulpitt CJ, Atherton DJ. Combined oral and nasal beclomethasone diproprionate in children with atopic eczema: a randomised controlled trial. Br Med J (Clin Res Ed) 1984; 289: 651-4.
18. Meggitt SJ, Gray JC, Reynolds NJ. Azathioprine dosed by thiopurine methyltransferase activity for moderate-to-severe atopic eczema: a double-blind, randomised controlled trial. Lancet 2006; 367: 839-46.
19. Granlund H, Erkko P, Eriksson E, Reitamo S. Comparison of cyclosporine and topical betamethasone-17,21-dipropionate in the treatment of severe chronic hand eczema. Acta Derm Venereol 1996; 76: 371-6.
20. Granlund H, Erkko P, Reitamo S. Long-term follow-up of eczema patients treated with cyclosporine. Acta Derm Venereol 1998; 78: 40-3.
21. Neuber K, Schwartz I, Itschert G, Dieck AT. Treatment of atopic eczema with oral mycophenolate mofetil. Br J Dermatol 2000; 143: 385-91.
22. Thestrup-Pedersen K, Andersen KE, Menne T, Veien N. Treatment of hyperkeratotic dermatitis of the palms (eczema keratoticum) with oral acitretin. A single-blind placebo controlled study. Acta Derm Venereol 2001; 81: 353-5.
23. Ruzicka T, Lynde CW, Jemec GBE et al. Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial. Br J Dermatol 2008; 158: 808-17.
24. Diepgen TL, Pfarr E, Zimmermann T. Efficacy and tolerability of alitretinoin for chronic hand eczema under daily practice conditions: results of the TOCCATA open study comprising 680 patients. Acta Derm Venereol 2012; 92: 251-5.
25. Bissonnette R, Worm M, Gerlach B et al. Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema. Br J Dermatol 2010; 162: 420-6.
26. Schmitt J, Schmitt N, Meurer M. Cyclosporin in the treatment of patients with atopic eczema a systematic review and metaanalysis. J Eur Acad Dermatol Venereol 2007; 21: 606-19.
27. Verma KK, Manchanda Y, Pasricha JS. Azathioprine as a corticosteroid sparing agent for the treatment of dermatitis caused by the weed Parthenium. Acta Derm Venereol 2000; 80: 31-2.
28. Scerri L. Azathioprine in dermatological practice. An overview with special emphasis on its use in non-bullous inflammatory dermatoses. Adv Exp Med Biol 1999; 455: 343-8.
29. Egan CA, Rallis TM, Meadows KP, Krueger GG. Low-dose oral methotrexate treatment for recalcitrant palmoplantar pompholyx. J Am Acad Dermatol 1999; 40: 612-4.
30. Ruzicka T, Larsen FG, Galewicz D et al. Oral alitretinoin (9-cis-retinoic acid) therapy for chronic hand dermatitis in patients refractory to standard therapy: results of a randomized, double-blind, placebo-controlled, multicenter trial. Arch Dermatol 2004; 140: 1453-9.